Michael Curi, MD
Vascular Surgery · Newark, NJNPI 1033222161
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,725 of the $32,311 with a category attached, or 70.3%. Humacyte Global, Inc. accounts for 70.2% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $24,268, more than ten times the $896 reported in 2019. Among vascular surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $329.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Humacyte Global, Inc.$23K
- Advanced Oxygen Therapy Inc.$3K
- Cook Medical LLC$2K
- W. L. Gore & Associates, Inc.$1K
- Silk Road Medical, Inc.$892
- Medtronic$755
- plus $2K from 16 others
Across 4 payments — averaging $2765.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Humacyte Global, Inc.$11K
What the payments were for
- Consulting fees$22,72570%
- Grants$6642%
- Travel & lodging$3,24210%
- Food & beverage$5,68018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Humacyte Global, Inc. | 10 | $22,674 |
| Advanced Oxygen Therapy Inc. | 2 | $2,946 |
| Cook Medical LLC | 25 | $1,797 |
| W. L. Gore & Associates, Inc. | 14 | $1,226 |
| Silk Road Medical, Inc. | 7 | $892 |
| Medtronic(2 entities) | 9 | $755 |
| Boston Scientific | 8 | $599 |
| Endologix LLC | 2 | $448 |
| Bolton Medical Inc | 3 | $388 |
| Kerecis Limited | 2 | $134 |
| Cardiovascular Systems Inc. | 1 | $118 |
| Inari Medical, Inc. | 2 | $67 |
| Abbott | 3 | $57 |
| Bard Peripheral Vascular, Inc. | 2 | $40 |
| Solventum Corporation | 1 | $34 |
| Shockwave Medical, Inc | 1 | $34 |
| Baxter Healthcare | 1 | $21 |
| Lemaitre Vascular, Inc. | 1 | $20 |
| Acera Surgical, Inc. | 1 | $18 |
| Cordis US CORP. | 1 | $16 |
| Cashflow Solutions, LLC | 1 | $14 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Symvess$22,502
- Topical oxygen chamber for extremities$2,925
- ENROUTE Transcarotid Neuroprotection System$903
- ENROUTE Transcarotid Stent$752
- ENROUTE .014 Guidewire$601
- ENHANCE Transcarotid Peripheral Access Kit$601
- GORE TAG Thoracic Endoprosthesis$504
- Torus Stent Graft System$448
- ENDOCROSS Device$448
- Kerecis SurgiClose$425
- Endurant$364
- TREO ABDOMINAL STENT-GRAFT SYSTEM$314
- Zenith Alpha$289
- EKOSONIC$267
- ENDURANT IIS$172
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$151
- Zenith Spiral-Z$142
- Cook$136
- GORE VIABAHN VBX Balloon Expandable Endo$135
- GENERAL NON VASCULAR INTERVENTION$128
How this compares
$32,311 in reported general payments places this provider in the 90th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $10,812 |
| ClopidogrelClopidogrel Bisulfate | 22 | $191 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Newark
- Karim SalemNewark$14K
- Michael SegalNewark$13K
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Laurel HastingsCamden$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.